NEW YORK, Sept. 23, 2015 /PRNewswire/ -- The market for bioreactors reached 240M in 2014 and will grow to nearly a half billion dollars in five years, according to healthcare research firm Kalorama Information. Bioreactors are chamber devices used to grow bacteria, yeast or other organisms used to produce drugs. The firm says that among other trends, to move towards disposable systems will drive new sales in this market. Kalorama made its estimate in its latest report, The Worldwide Market for Bioreactors.
The report says bioreactors are changing from fixed stainless steel stirred forms usually in capacities in a range up to 25,000 liters, to smaller, single-use bioreactors. Due to some of the challenges experienced with traditional fixed-in-place biomanufacturing facilities, there has been a desire to create more flexible ones. The development of and improvements to single use stirred bioreactors have offered a more flexible and cost effective alternative.
"The challenge with this traditional stainless steel bioreactors is that these facilities have large manufacturing capacity, but little flexibility," said Joe Constance, Kalorama Information analyst and the author of the report.
Several trends align with the popularity of single-use bioreactors. There has been a growing need to produce more biopharmaceutical product at smaller volumes. With single use systems, the need for cleaning, sterilization and validation processes is reduced or eliminated, making it possible to produce several products in the same facility in smaller lot sizes. With product globalization, there is a desire to manufacture medicines closer to the populations that they will be supplied to. Single use bioreactors and systems will be designed to replicate facilities in different regions.
"In spite of the evolution of single use bioreactors, they will not completely replace stainless steel units," Constance says. "When it concerns large volume production, if a manufacturer already has a stainless facility established which is functional and fully depreciated, single use technology would find it difficult to compete with this type of facility."
The report says the biopharmaceutical industry has become extremely been open to the adoption of single use bioprocessing systems, including single use bioreactors. Disposable components and processing systems have found their own market niches and segmentations that continue to grow. The market has become a continuous dynamic environment for these products.
Kalorama Information's report, The Worldwide Market for Bioreactors, details markets for bioreactors by type (single user/stainless steel), application, region of the world sold. Market share is also provided. The report makes projections about the market in a five year forecast. Detailed trend analysis and competitor profiles are included in the report. The report can be purchased at: http://www.kaloramainformation.com/redirect.asp?progid=87812&productid=9258385.
About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.
We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog at www.kaloramainformation.com.
SOURCE Kalorama Information